Disparities in Human Papillomavirus Vaccine Series Completion by Adolescent Males: A Retrospective Cohort Study.


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
04 2020
Historique:
received: 15 04 2018
revised: 18 04 2019
accepted: 04 05 2019
pubmed: 21 5 2019
medline: 18 3 2021
entrez: 21 5 2019
Statut: ppublish

Résumé

Human papillomavirus (HPV) vaccine has been recommended for male patients for the prevention of genital warts and precancerous anal lesions since 2009. Our objective was to characterize race and insurance-based disparities in HPV vaccine completion among male patients who initiated the HPV vaccine series. This was a retrospective cohort study of adolescent male patients in a primary care network who initiated the HPV vaccine series from October 2009 to December 2013. We measured vaccine series completion as the primary outcome. We evaluated associations between outcomes and race and insurance status, controlling for potential confounders and effect modification with multivariable logistic regression. Analyses were stratified by vaccine recommendation era (permissive vs routine). In total, 42% of males in the cohort (16,691) completed the vaccine series. In the permissive vaccine era (2009-2011), non-black patients (53%) were more likely to complete than black patients (32%) and non-Medicaid patients (49%) were more likely to complete than Medicaid patients (33%). These differences persisted in the routine recommendation era (2012-2013). In both the permissive and routine eras, Medicaid insurance was associated with a larger reduction in the predicted probability of vaccine series completion for non-black patients. Adherence to the recommended vaccination schedule was low, with a median time to completion of 8.9 months. Using the updated completion schedule (2016), we found that completion rates were greater (54.1%) with continued differences based on race (60% vs 45.7% for non-black vs black patients) and insurance (57.4% vs 46.4% completion for non-Medicaid vs Medicaid patients). We found significant disparities in HPV vaccine series completion rates among male patients based on race and insurance, unchanged based on era of initiation or visit frequency.

Identifiants

pubmed: 31108236
pii: S1876-2859(19)30128-7
doi: 10.1016/j.acap.2019.05.002
pii:
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-373

Informations de copyright

Copyright © 2019 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Atu Agawu (A)

Division of General Pediatrics (A Agawu, AG Fiks). Electronic address: agawua@email.chop.edu.

Alexandra L Hanlon (AL)

School of Nursing, University of Pennsylvania (AL Hanlon, AM Buttenheim).

Alison M Buttenheim (AM)

School of Nursing, University of Pennsylvania (AL Hanlon, AM Buttenheim).

Lihai Song (L)

Healthcare Analytics Unit, PolicyLab (L Song), Children's Hospital of Philadelphia.

Alexander G Fiks (AG)

Division of General Pediatrics (A Agawu, AG Fiks).

Kristen A Feemster (KA)

Division of Infectious Diseases (KA Feemster).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH